Abstract-Brain lipid composition
Thiamine deficiency still occurs frequently in countries where polished rice is the main dietary constituent
(1). In addition, chronic alcoholism has been reported to cause thiamine deficiency because ethanol impairs the intestinal absorption of thiamine (2). Severe thiamine deprivation affects the nervous system by causing peripheral neuro pathy (3-5), and central nervous system lesions such as those in the Wernicke Korsakoff syndrome and Leigh's disease (6, 7). Wernicke's encephalopathy is a disorder of thiamine deficiency manifested by mental confusion, ataxia and coma. In the lesions of Wernicke's encephalopathy,edematous necro sis of the astroglia, oligodendroglia, myelin, and neurons combined with petechial hemor rhage appear predominantly (8). Similar clinical manifestations and brain morpholo gical changes have been described in experi mental animals treated with a thiamine de ficient diet (TDD) and/or thiamine antime tabolites (9, 10). We already reported that morphological changes were observed in the rat brain in acute thiamine deficiency induced by administration of oxythiamine (OT), pyri thiamine (PT) and/or TDD (1 1). The central nervous system lesions in thiamine deprived rats consisted of abnormal endothelial cells and pericyte swelling or vacuolation of astrocytes, nerve cells containing distorted organelles and myelin degeneration. Especial ly, PT or TDD treated rats showed the charac teristic central nervous tissue alterations of myelin degeneration.
However, the patho genesis of the encephalopathy induced by thiamine deficiency is not fully understood.
The myelin sheath consists of various kinds of lipids, and thiamine diphosphate works as a coenzyme in lipid and glucose metabolism. Therefore, an alteration of lipid metabolism may be related to the pathogene sis of thiamine deficiency encephalopathy. The present study was undertaken to inves tigate the alteration in brain lipid composition in OT-, PT or TDD-induced thiamine de ficient rats and to discuss the pathogenesis of morphological changes in the brain induced by thiamine deficiency.
Materials and Methods Animal and drug administration: Male Sprague-Dawley rats, 4 weeks of age at the start of the experiments, were fed with a stock diet (MF, Oriental Kobo Co., Ltd.) and tap water ad libitum under standard laboratory conditions (23±2°C, 55±15% humidity). The rats were divided into five groups: regular diet (C), PT treated, OT treated, TDD and a pair fed control (PFC) groups.
Thiamine-HCI, oxythiamine-HCI and pyri thiamine-HBr were kindly supplied from Takeda Chemical Ind., Ltd. (Osaka, Japan). TDD was purchased from Nippon Clea Co., Ltd. (Tokyo, Japan). TDD was a purified powder containing a subproportional level of thiamine (thiamine: 0.5 mg/kg of diet). The treatment period was 9 days for all groups. In the OT or PT group, rats were fed with a regular diet (thiamine: 9 mg/kg of diet) for 3 days and then injected intraperitoneally with PT (500 ug/kg/day) or OT (40 mg/kg/day) for 6 days while maintained on a regular diet. In the TDD group, rats were fed with TDD during the same periods (9 days). The PFC group was fed with TDD for the first 3 days and supplemented with adequate amounts of thiamine (5 mg/kg/day, i.p.) for the sub sequent 6 days while maintained on a TDD.
Lipid extraction: Animals were sacrificed by decapitation on the day after the 9-day treatment was over. Brains were rapidly re moved and dissected into four areas (cerebral cortex, subcortical structures, brain stem and cerebellum). These four areas were obtained as described by Henderson and Schenker (12) . Lipids of the individual brain regions were extracted essentially as outlined by Folch et al. (13) . Briefly, an individual brain region was homogenized by hand in 20 volumes of chloroform/methanol (2:1, v/v) with butylated hydroxytoluene (20 mg/100 ml of solvent) in a tissue grinder. That is, the brain homogenate from 1 g of wet tissue
weight was diluted to a volume of 20 ml. The volume of a tissue sample was calculated on the assumption that the volume of 1 g of tis sue was 1 ml. After the residue was reex tracted with the same solvent mixture, the washing procedure to remove all the non lipid contaminants from the crude extracts was carried out by adding 0.9% NaCI solution. After rewashing the lower phase of the lipid from the homogenized mixtures, the solvent was evaporated at low temperature (less than 40°C) under a stream of nitrogen. The residue was dissolved in a volume of chloroform/ methanol (2:1, v/v) equivalent to one-tenth the original volume, because each residue weight was about one-tenth of the original wet weight of brain tissue.
Chemical assays: Total lipid content of the brain lipid extracts was determined by the method of Bragdon (14). Total cholesterol content of the brain lipid extracts was deter mined by a colorimetric method (Cholesterol B Test). Phospholipid and triglyceride con tents of the brain lipid extracts were deter mined enzymatically (Phospholipid-B Test and Triglyceride-G Test, respectively). These assays were performed using commercial kits (Wako Pure Chemical Ind., Ltd., Tokyo). The results on all lipid contents were express ed in terms of wet tissue weight. The yield of total lipid, total cholesterol, triglyceride and phospholipid expressed as a percentage of the dry weight was about 40-50%, 10%, 10% and 30-40%, respectively. Sphingomyelin and cerebroside assay: Sphingomyelin and cerebroside were assayed by first isolating them from lipid aliquots by thin-layer chromatography (TLC plate silica gel 60, Merck) using chloroform/methanol/ water (65:25:4, v/v) as the developing solvent. The plates were allowed to dry at room temperature for 1-2 hr. Before the ex periment, the plates were activated at 120°C for 2 hr. Samples (50 , g or less) were applied to the thin-layer chromatography plate with standardized micropipettes. Reference com pounds (sphingomyelin and cerebroside, Sigma Chemical Co., St. Louis), ranging in amounts from 15 to 50 ,ag, were applied together with tissue lipid extracts. Spots were visualized by exposure to H2SO4 vapors (3 ml of 50% solution) and after drying, the silica gel plate was heated on a hot plate (2 kW) for 30-40 min. The densities of sphingomyelin and cerebroside spots were measured in com parison with the values of the known amounts of reference compounds using a densitometer (F-808, Cosmo Co., Ltd., Japan). The results on sphingomyelin and cerebroside contents are expressed in terms of wet tissue weight.
Statistical analysis: Results were expressed as the mean±S.D. from 4 to 7 rats per group. Statistical significance was evaluated using Student's t-test. Fig. 1 . Effect of PT, OT and TDD treatments on body weight gain. PT and OT rats were treated as fol lows: Rats were intraperitoneally injected with pyrithiamine (PT: 500 pg/kg/day) or oxythiamine (OT: 40 mg/kg/day) for 6 days with regular diet (thiamine content: 9 mg/kg of diet). In the TDD group, rats were fed with a thiamine deficient diet (thiamine: 0.5 mg/kg of diet) for 9 days. PFC rats were fed with TDD for the first 3 days and then supplemented with adequate amounts of thiamine (5 mg/kg/day, i.p.) for the subsequent 6 days while maintained on a TDD. The body weight gain is expressed as the ratio of the body weight to that at the start of the experiment.
Each value of body weight gain represents the mean of 6-8 specimens.
`: Significant differences from the control value with P<0.05 (Student's t-test).
Results
1. Physical changes and neurological symptoms: The body weight gain of the OT or TDD group rats was slightly lower compared with that of the regular diet control rats (Fig .  1) . Weights of whole brain were similar in all groups in this experimental period (data not shown). PT, OT or TDD treated rats developed anorexia and early neurological signs such as mild ataxic gait and tendency to walk back wards by the 8-10th day. However, marked physical changes and neurological symptoms were not observed in any treated group during this experimental period.
2. Total lipid: Total lipid levels in four brain regions in PT, OT or TDD treated rats and PFC rats are shown in Fig. 2 . Total lipid levels in the cerebral cortex and the subcortical structure significantly increased in OT and TDD group rats, but PFC did not ameliorate the increase in total lipid levels observed in the TDD group. OT treatment also increased the total lipid level in the brain stem or the cerebellum. On the other hand, PT treatment decreased the total lipid level in the cerebel lum remarkably.
3. Total cholesterol: As shown in Fig. 3 , total cholesterol levels in four brain regions show the tendency to increase in all groups of treated rats. PFC did not ameliorate the in crease in total cholesterol level observed in TDD treatment.
4. Triglyceride and phospholipid: Changes in triglyceride levels in four brain regions in PT, OT or TDD treated rats and PFC rats are shown in Fig. 4 . In the brain stem, OT, TDD and PFC groups showed a dramatic decrease in triglyceride levels. However, no apparent changes were observed in other brain regions, and PT treatment induced no changes in any of the brain regions. No significant changes in phospholipid levels after treatments with PT, OT and TDD were observed in any of brain regions (data not shown).
5. iorated the decrease in cerebroside levels ob served in the TDD group. Changes in sphin gomyelin levels in four brain regions in all groups were studied. In the subcortical struc ture and the brain stem, sphingomyelin levels of the OT group tended to show a mild de crease, but this was not significant because of the wide variation of the control values (data not shown). system. In experimental animals, a lack of dietary thiamine induces well-defined region specific lesions in the central nervous system that correlate with neurological symptoms (15, 16) . In the present study, no severe neurological symptoms were observed on the day after the 9-day treatment with TDD, OT, PT or PFC was over, except early neurological signs such as mild ataxic gait and tendency to walk backwards. Several factors can be con sidered to have caused these mild neurologi cal symptoms.
One is the short period of treatments and another is the age of used rats. In addition PT or OT treated rats were fed on regular diet containing thiamine in the present study. Our previous paper indicated that thiamine antimetabolites injection with TDD feeding induced more severe thiamine de ficiency and neurophysiological changes (3, 4, 5, 11 ). Especially, PT causes a significant central muscarinic, cholinergic and serotoner gic defect (17, 18). Many factors could be conceived as causes for the various changes of neurological symptoms.
However, our previous report demon strated that the pathological change in the brain of TDD or PT treated rats preceded ap parent neurological symptoms. Spongy re ticulation and degeneration of nerve cells were found in the anterior and posterior floor of the fourth ventricle and inferior cerebellar peduncle (11). In addition, electron micro graphs of the OT, PT and/or TDD treated rat brain revealed irregular myelin sheath, vacuo lation of glial foot process or neuropile, swel ling of extracellular space or change of myelinated axon filled with the collection of membranous structures (11 ). Collins also reported that the microscopic appearance of the central nervous system lesions in thiamine deprived animals revealed selective destruc tion of myelinated structures (15). Moscatelli et al. reported that the low thiamine and low protein diet produced a decrease in myelin sphingomyelin expressed as relative molar amounts in the rat brain (19). Our data also showed the tendency of decrease in sphingo myelin in the brain stem and the subcortical structure of the rat brain without severe neurological symptoms. These parts of the brain are more vulnerable in thiamine de ficiency induced by PT, OT and/or TDD. Sphingomyelin and cerebroside are generally regarded as characteristic lipids of myelin (9), and their levels can be regarded as a measure showing the degree of myelination.
In the present study, cerebroside levels in thiamine deficient rats were shown to decrease re markably and the PFC group showed the ameliorating effect. These results on cere broside and sphingomyelin provide evidence for changes of the myelin degradation in the central nervous system induced by thiamine deficiency.
The present study revealed that levels of all brain lipids except phospholipid were changed significantly in thiamine deficient rats. As to the total phospholipid concentra tion, Geel et al. also reported that no changes were evident in the whole brain of thiamine deficient rats (20) . In the present study, we found that the total cholesterol level of all treated rats and total lipid level of OT or TDD treated rats increased. Many reports indicated that thiamine deficiency reduced the activity of brain transketolase and pyruvate decar boxylase in animals (21, 22) . Thiamine diphosphate is an essential coenzyme for transketolase which catalyzes reactions nec essary for the operation of the hexose mono phosphate (H M P) shunt of the major pathway of NADPH synthesis. In addition, thiamine diphosphate works as a coenzyme for py ruvate decarboxylase which catalyzes the oxidative conversion of pyruvate to acetyl CoA (22). Therefore, the increases in brain total cholesterol and total lipid level observed in this experiment are intriguing results. These increases in brain lipids might result from an adaptive response to thiamine deficiency, considering that Itokawa suggested that the increase in lipogenesis occurred despite of the decrease in liver total cholesterol and total lipid in thiamine deficient animals (23).
Thiamine antagonists, OT and PT, have been reported to block the coenzyme func tions of thiamine.
PT readily crossed the blood-brain barrier and PT diphosphate di rectly inhibited the activity of thiamine pyro phosphokinase (24). In PT treated rats, our result showed the decreases in cerebroside level in three brain regions and total lipid level in the cerebellum, while the triglyceride level in the brain stem remained constant. The pat tern of changes was different from that ob served in other treated rats. Moreover, our previous paper (11) revealed that myelin degradation in the brain stem was especially severe on PT or TDD treated rats as compared to that in the OT treated animals. On the other hand, OT competed with thiamine diphos phate for apo-enzyme by OT diphosphate and induced a decrease in thiamine availability (24) (25) (26) .
OT treated rats and TDD rats showed the similar changes in brain lipids and the decrease in body weight gain due to the apparent anorexia. Bai et al. (27) suggest ed that the development of anorexia symp toms correlated most closely with the de crease in transketolase activity. Since malnu trition due to anorexia has been shown to alter lipid composition in the developing rat brain (28), we cannot rule out the possibility that these changes in brain lipid composition in OT or TDD treated rats are related to malnutrition.
Dreyfus (9) reported that cerebroside con centrations in the whole brain of 25-day-old thaimine deficient rats were reduced, and pair-fed control rats showed a more severe decrease. These studies were performed in immature animals whose thiamine deficiency was induced by feeding pregnant mothers with a diet containing suboptimal amounts of thiamine (0.5 mg/kg of diet). Using 4 week-old rats, we found that the cerebroside level in the cerebral cortex, subcoitical struc ture and brain stem decreased after PT, OT or TDD treatment and demonstrated that thia mine given in adequate amounts to TDD treated rats showed ameliorative effects. From these studies, we can imagine that thiamine deficiency in suckling or weanling rats in duces more sever damage in the brain and this can not be restored by thiamine addition. Our previous paper (11) demonstrated that brain thiamine levels of PT (500 ug/kg, i.p. X 6 days) treated rats fell to 42.9% of those of the regular-diet control in whole brain. TDD treatments induced a mild decrease in the brain, while OT treated rats showed no change in brain thiamine levels without the apparent myelin degradation. By the report of Rindi et al. (25) , OT does not penetrate the brain and therefore OT diphosphate was not observed there. As to the relationship between the brain thiamine contents and changes in brain lipids, no simple correlation was observed. In thiamine depleted rats, the total thiamine level is much better maintained in the brain than the total thiamine level in other organs. This control of entry of thiamine into the cerebrospinal fluid and brain is an important part of the homeostatic mechanisms of total thiamine regulation in the brain (29). McCan dless et al. reported that thiamine-deficient encephalopathy and the impairment of cere bral transketolase and pyruvate decarboxylase activities occurred primarily in the brain stem and cerebellum, the sites of the morphological changes (21). The determination of ac tivities of thiamine dependent enzymes or contents of thiamine diphosphate in each brain region will reveal the more specific re lationship between thiamine deficiency and changes in brain lipids.
